PAR paradigm biopharmaceuticals limited..

Ann: Loyalty and Piggyback Options Program, page-542

  1. 1,981 Posts.
    lightbulb Created with Sketch. 347
    Personally I think the options are overpriced atm. The latest announcement doesn't give any new info re a deal just says "the company is actively pursuing strategic partnerships and non/less dilutive funding opportunities"
    Until they announce a deal there's always a chance of yet another CR then the options will likely be worthless when they expire in a year not 2028 that's the piggyback options and you only get them if you exercise the options.
    Has the word "less dilutive" been used before when describing deals or has it always been non dilutive?
    Less dilutive could imply giving stock to a potential partner which would be a good thing IMO
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
32.5¢
Change
0.035(12.1%)
Mkt cap ! $126.5M
Open High Low Value Volume
29.0¢ 33.5¢ 29.0¢ $692.3K 2.176M

Buyers (Bids)

No. Vol. Price($)
1 11161 32.5¢
 

Sellers (Offers)

Price($) Vol. No.
33.0¢ 134295 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.